Clinical Trials
6 trialsNCT07320781 2026-01-08
Role of Preoperative Tapentadol in Reduction of Perioperative Analgesic Requirement After Breast Conservative Surgery in Cancer Patients.
Shaukat Khanum Memorial Cancer Hospital & Research Centre
Phase NA Completed
NCT00472303 2019-11-04
A Study to Evaluate Tapentadol (CG5503) in the Treatment of Chronic Tumor-Related Pain Compared With Placebo and Morphine
Grünenthal GmbH
Phase 3 Completed
NCT01264887 2019-11-04
Tapentadol in Chronic Malignant Tumour Related Pain
Grünenthal GmbH
Phase 3 Terminated
NCT00505414 2019-11-01
A Study to Evaluate the Effectiveness and Safety of CG5503 (Tapentadol) in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine
Grünenthal GmbH
Phase 3 Terminated
NCT01165281 2017-07-21
A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
Janssen Research & Development, LLC
Phase 3 Completed
NCT00805142 2013-07-29
Phase 2 Study of Tapentadol Prolonged Release in Cancer Pain Participants
Janssen Pharmaceutical K.K.
Phase 2 Completed